Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NM › Roswell › NPI 1972878361
Hospital

Lovelace Health System LLC

Lovelace Health System LLC was paid $20.13M by Medicaid between Jan 2018 and Dec 2024, across 211 billing codes. Its largest line is 99284, emergency room visit (serious) — 27% of everything it billed.

33Billing provider infoLOVELACE HEALTH SYSTEM LLC
ROSWELL, NM 88201
33aNPI1972878361assigned 03/19/2012
33bProvider typeGeneral Acute Care Hospital
28Total paid$20.13M
24GClaims321,068
24DCodes billed211
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Mexico

Rank by total paid#13 of 24
Median peer was paid$20.13M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official PETROVICH, STEPHEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201844,574$3.00M
201930,516$2.07M
202027,843$1.76M
202138,835$2.29M
202261,388$3.44M
202367,588$4.00M
2024incomplete50,324$3.56M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 27% 22,381 21,008 $5.35M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 15,931 15,362 $2.72M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 10% 8,298 7,777 $2.07M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.9% 1,978 1,880 $785K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 3.3% 884 660 $670K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2.6% 5,505 5,317 $521K
70450 Computed tomography, head or brain; without contrast material 2.3% 2,204 2,126 $472K
D2930 Prefabricated stainless steel crown - primary tooth 2.0% 404 390 $401K
96375 Therapeutic injection; each additional sequential IV push 1.9% 5,700 5,073 $375K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.9% 9,055 8,451 $374K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.8% 1,311 1,266 $356K
71045 Radiologic examination, chest; single view 1.6% 5,428 5,053 $325K
199 more codes
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.6% 6,308 $325K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.5% 7,074 $292K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.1% 20,405 $231K
80053 Comprehensive metabolic panel 1.1% 17,579 $227K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.1% 2,607 $220K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.1% 1,784 $220K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.0% 4,237 $207K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.0% 2,024 $205K
71046 Radiologic examination, chest; 2 views <1% 2,961 $172K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,816 $168K
49083 <1% 459 $151K
D3220 Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction <1% 272 $142K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,933 $137K
96361 Intravenous infusion, hydration; each additional hour <1% 2,445 $136K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,465 $130K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,284 $129K
81001 <1% 12,930 $115K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,274 $110K
36415 Collection of venous blood by venipuncture <1% 23,905 $93K
74018 <1% 1,181 $91K
84443 Thyroid stimulating hormone (TSH) <1% 3,629 $87K
73562 <1% 844 $83K
84484 <1% 3,996 $74K
P9047 Infusion, albumin (human), 25%, 50 ml <1% 457 $71K
72100 <1% 835 $70K
73610 <1% 755 $70K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,130 $65K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,639 $61K
87634 <1% 973 $60K
86141 <1% 3,308 $56K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 252 $54K
73030 <1% 565 $47K
83880 <1% 1,882 $46K
73630 <1% 708 $43K
87650 <1% 1,150 $43K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 655 $38K
85610 <1% 4,236 $37K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 455 $37K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,168 $36K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 83 $34K
83690 <1% 4,165 $34K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 896 $32K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 896 $32K
G0378 Hospital observation service, per hour <1% 63 $30K
70486 <1% 144 $28K
D7140 Extraction, erupted tooth or exposed root <1% 61 $28K
73130 <1% 472 $28K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 724 $28K
85730 <1% 2,645 $26K
74022 <1% 320 $25K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 309 $25K
80074 <1% 348 $24K
81025 <1% 3,609 $24K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,187 $24K
87631 <1% 249 $23K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,089 $22K
D2391 Resin-based composite - one surface, posterior, primary or permanent <1% 38 $21K
82553 <1% 2,269 $21K
80061 Lipid panel <1% 2,008 $21K
84702 <1% 1,207 $21K
71250 <1% 102 $20K
73110 <1% 287 $19K
80048 Basic metabolic panel (calcium, ionized) <1% 1,931 $18K
J7030 Infusion, normal saline solution , 1000 cc <1% 3,220 $18K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 147 $18K
83605 <1% 908 $18K
82550 <1% 2,360 $17K
87077 <1% 1,053 $17K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 21 $17K
82150 <1% 1,797 $13K
J2704 Injection, propofol, 10 mg <1% 2,362 $13K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 174 $13K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 254 $13K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 27 $13K
83036 Hemoglobin; glycosylated (A1C) <1% 1,708 $12K
87040 <1% 985 $12K
J7050 Infusion, normal saline solution, 250 cc <1% 2,287 $11K
72125 Computed tomography, cervical spine; without contrast material <1% 57 $11K
J3300 Injection, triamcinolone acetonide, preservative free, 1 mg <1% 466 $10K
83735 <1% 1,311 $10K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,286 $10K
84439 <1% 1,342 $9K
72131 <1% 42 $9K
85379 <1% 498 $9K
85652 <1% 1,020 $7K
96376 <1% 323 $7K
76801 <1% 97 $7K
82962 <1% 3,020 $7K
72040 <1% 78 $6K
76770 <1% 60 $6K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,158 $6K
97032 <1% 354 $6K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 363 $6K
87186 <1% 735 $6K
83540 <1% 235 $6K
71275 Computed tomographic angiography, chest, with contrast material <1% 13 $6K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 49 $6K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 13 $6K
D2330 <1% 12 $6K
86780 <1% 351 $5K
76536 <1% 42 $5K
87070 <1% 215 $5K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 154 $5K
93971 <1% 51 $5K
86900 <1% 447 $4K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,605 $4K
81003 <1% 2,134 $4K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 168 $4K
86901 <1% 448 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,855 $4K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 13 $4K
90715 <1% 274 $4K
99213 Doctor's office visit, returning patient (routine) <1% 26 $4K
84112 <1% 93 $4K
85651 <1% 420 $4K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 89 $4K
82607 <1% 310 $4K
86696 <1% 147 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,707 $3K
84703 <1% 309 $3K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,517 $3K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 484 $3K
74019 <1% 24 $3K
82731 <1% 31 $3K
84481 <1% 255 $3K
97010 <1% 214 $3K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 619 $2K
82570 <1% 298 $2K
82728 <1% 255 $2K
73080 <1% 27 $2K
C1769 Guide wire <1% 140 $2K
73502 <1% 39 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,340 $2K
97165 <1% 67 $2K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 376 $2K
82043 <1% 159 $2K
86695 <1% 147 $2K
99152 <1% 25 $2K
83615 <1% 106 $2K
82565 <1% 357 $2K
73090 <1% 25 $2K
85027 <1% 204 $2K
59025 Fetal non-stress test <1% 13 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 368 $2K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 12 $2K
73560 <1% 26 $1K
97166 <1% 43 $1K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 902 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 734 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 795 $1K
86038 <1% 160 $1K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 374 $1K
76942 <1% 12 $1K
76857 <1% 13 $1K
87807 <1% 74 $1K
12001 <1% 14 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 487 $998.33
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes <1% 13 $858.65
84550 <1% 121 $810.89
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 479 $721.76
97161 <1% 32 $689.64
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 222 $648.86
86850 <1% 87 $604.29
73590 <1% 13 $583.52
A9270 Non-covered item or service <1% 1,189 $571.77
J3490 Unclassified drugs <1% 15 $538.45
80050 General health panel <1% 20 $520.50
87205 <1% 55 $507.77
J1596 Injection, glycopyrrolate, 0.1 mg <1% 89 $488.03
85007 <1% 58 $429.07
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 235 $401.17
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 17 $391.77
87081 <1% 53 $301.41
84153 <1% 12 $273.76
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 84 $268.49
87075 <1% 26 $267.48
J0780 Injection, prochlorperazine, up to 10 mg <1% 106 $259.73
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 47 $218.72
83525 <1% 26 $215.13
84100 <1% 42 $201.83
J1171 Injection, hydromorphone, 0.1 mg <1% 54 $190.91
J1644 Injection, heparin sodium, per 1000 units <1% 99 $180.38
J0687 Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg <1% 92 $116.38
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 188 $108.66
V2632 Posterior chamber intraocular lens <1% 772 $107.07
J7510 Prednisolone oral, per 5 mg <1% 102 $105.04
82248 <1% 15 $85.64
83550 <1% 16 $83.44
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 136 $77.46
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 98 $73.05
82746 <1% 12 $61.66
J2060 Injection, lorazepam, 2 mg <1% 46 $58.67
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 34 $58.46
C9113 Injection, pantoprazole sodium, per vial <1% 43 $55.16
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 13 $55.16
J3370 Injection, vancomycin hcl, 500 mg <1% 14 $54.35
J1956 Injection, levofloxacin, 250 mg <1% 13 $24.36
A4615 Cannula, nasal <1% 40 $8.94
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 50 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPETROVICH, STEPHEN (SVP)
Parent organizationARDENT LEGACY HOLDINGS LLC
Same official

Other billing entities under PETROVICH, STEPHEN

Full network →
ProviderLocationPaid
Lovelace Health System, LLCAlbuquerque, NM$57.71M
Lovelace Health System LLCAlbuquerque, NM$45.27M
Southwest Medical Associates, LLCAlbuquerque, NM$41.40M
Lovelace Health System, LLCAlbuquerque, NM$31.24M
Jacksonville Hospital LLCJacksonville, TX$9.41M
Henderson Hospital, LLCHenderson, TX$8.52M
Athens Hospital, LLCAthens, TX$8.32M
Etmc Physician Group INC.Tyler, TX$8.03M
Tyler Regional Hospital LLCTyler, TX$7.94M
Lovelace UNM Rehabilitation Hospital LLCAlbuquerque, NM$6.30M
Pocatello Hospital LLCPocatello, ID$6.11M
Jacksonville Hospital LLCJacksonville, TX$5.93M
Ahs Pryor Hospital, LLCPryor, OK$5.61M
Bsa Hospital LLCAmarillo, TX$4.96M
Pittsburg Hospital LLCPittsburg, TX$4.83M
Ahs Claremore Regional Hospital, LLC.Claremore, OK$4.81M
Ahs Henryetta Hospital LLCHenryetta, OK$4.27M
Pittsburg Hospital LLCPittsburg, TX$3.98M
Topeka Hospital, LLCTopeka, KS$3.94M
Ahs Pryor Hospital, LLCPryor, OK$3.76M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.